Pages that link to "Q33722100"

The following pages link to Human Menstrual Blood-Derived Stem Cells Ameliorate Liver Fibrosis in Mice by Targeting Hepatic Stellate Cells via Paracrine Mediators (Q33722100):

Displaying 22 items.

• A Pilot Study Evaluating the Safety of Intravenously Administered Human Amnion Epithelial Cells for the Treatment of Hepatic Fibrosis (Q41526136) (← links)
• Human menstrual blood-derived mesenchymal stem cells as a cellular vehicle for malignant glioma gene therapy (Q41709256) (← links)
• The Clinical Applications of Endometrial Mesenchymal Stem Cells (Q47229258) (← links)
• Heterogenic transplantation of bone marrow-derived rhesus macaque mesenchymal stem cells ameliorates liver fibrosis induced by carbon tetrachloride in mouse (Q49433535) (← links)
• Transplantation of Human Menstrual Blood-Derived Mesenchymal Stem Cells Alleviates Alzheimer's Disease-Like Pathology in APP/PS1 Transgenic Mice. (Q54217663) (← links)
• The Reparative Abilities of Menstrual Stem Cells Modulate the Wound Matrix Signals and Improve Cutaneous Regeneration. (Q55246388) (← links)
• Human menstrual blood: a renewable and sustainable source of stem cells for regenerative medicine (Q59336187) (← links)
• The multi-functional roles of menstrual blood-derived stem cells in regenerative medicine (Q60922074) (← links)
• Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis (Q64249008) (← links)
• Human Menstrual Blood-Derived Stem Cells Inhibit the Proliferation of HeLa Cells via TGF-β1-Mediated JNK/P21 Signaling Pathways. (Q64964155) (← links)
• Transplantation of mesenchymal stem cells and their derivatives effectively promotes liver regeneration to attenuate acetaminophen-induced liver injury (Q89924314) (← links)
• Mesenchymal stem cell therapies for liver cirrhosis: MSCs as "conducting cells" for improvement of liver fibrosis and regeneration (Q90087662) (← links)
• Human Liver-Derived Stem Cells Improve Fibrosis and Inflammation Associated with Nonalcoholic Steatohepatitis (Q91688717) (← links)
• Clinical study of mesenchymal stem cell treating acute respiratory distress syndrome induced by epidemic Influenza A (H7N9) infection, a hint for COVID-19 treatment (Q91944149) (← links)
• Menstrual blood-derived stem cells: toward therapeutic mechanisms, novel strategies, and future perspectives in the treatment of diseases (Q92173428) (← links)
• Exploring the Most Promising Stem Cell Therapy in Liver Failure: A Systematic Review (Q92219344) (← links)
• Optimization of lentiviral transduction parameters and its application for CRISPR-based secretome modification of human endometrial mesenchymal stem cells (Q92423873) (← links)
• Genome-wide DNA methylation and hydroxymethylation analysis reveal human menstrual blood-derived stem cells inhibit hepatocellular carcinoma growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements (Q92447145) (← links)
• Menstrual Blood Stem Cell Transplantation in Mice Model of Acute Liver Failure: Does Gender of Recipient Affect the Outcome? (Q92462729) (← links)
• Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients (Q95314575) (← links)
• The clinical application of mesenchymal stem cells in liver disease: the current situation and potential future (Q98291533) (← links)
• Menstrual blood-derived stromal cells modulate functional properties of mouse and human macrophages (Q104111207) (← links)